Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment
Work
Year: 2023
Type: article
Source: Biomaterials
Institution China Pharmaceutical University
Cites: 78
Cited by: 21
Related to: 10
FWCI: 7.981
Citation percentile (by year/subfield): 99.95
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed
Funders National Natural Science Foundation of China, National Natural Science Foundation of China, National Natural Science Foundation of China
Grant IDS 82073175, 82272801, 81872424